HIG insider exercise-and-sale: 7,841 shares at $122.41 avg
Rhea-AI Filing Summary
HIG — Insider transaction disclosed. An Executive Vice President reported an option exercise and same-day sale on 10/29/2025. The officer exercised 7,841 stock options at an exercise price of $51.87 per share and sold 7,841 common shares at a $122.4116 weighted average price.
Following these transactions, the officer directly owned 18,399.962 common shares. The exercised option series (strike $51.87, expiring 02/23/2031) shows 5,681 options remaining. Other option grants outstanding include strikes of $69.41 (30,193 shares, expiring 02/23/2032), $78.28 (26,079 shares, expiring 02/28/2033), $95.74 (11,399 shares, expiring 02/27/2034), and $116.41 (9,467 shares, expiring 02/25/2035). The sale price reflected a range of $122.40–$122.54 per share.
Positive
- None.
Negative
- None.
Insights
Routine exercise-and-sale by an HIG executive; neutral signal.
The filing shows a standard same-day option exercise and sale: 7,841 options at an exercise price of $51.87 were exercised on 10/29/2025, and an equal number of common shares were sold at a weighted average of $122.4116. This is a typical liquidity event tied to vested awards.
Post-transaction, direct common holdings are 18,399.962 shares. The specific option series exercised (expiring 02/23/2031) has 5,681 options remaining. Additional grants remain outstanding at exercise prices of $69.41, $78.28, $95.74, and $116.41, with expirations from 2032 to 2035.
Because this reflects routine insider equity administration rather than an operational change, the investment thesis impact is neutral based on this disclosure alone.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option | 7,841 | $0.00 | -- |
| Exercise | Common Stock | 7,841 | $51.87 | $407K |
| Sale | Common Stock | 7,841 | $122.4116 | $960K |
| holding | Stock Option | -- | -- | -- |
| holding | Stock Option | -- | -- | -- |
| holding | Stock Option | -- | -- | -- |
| holding | Stock Option | -- | -- | -- |
Footnotes (1)
- Price reflected is the weighted average sale price for shares sold. The range of sales prices for the transactions reported was $122.40 - $122.54 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. The options became fully exercisable on February 23, 2024, the third anniversary of the grant date. The options became fully exercisable on February 23, 2025, the third anniversary of the grant date. One-third of the options became exercisable on February 28, 2024, an additional one-third of the options became exercisable on February 28, 2025 and the remaining one-third of the options will become exercisable on February 28, 2026, the third anniversary of the grant date. One-third of the options became exercisable on February 27, 2025, an additional one-third of the options will become exercisable on February 27, 2026 and the remaining one-third of the options will become exercisable on February 27, 2027, the third anniversary of the grant date. One-third of the options will become exercisable on February 25, 2026, an additional one-third of the options will become exercisable on February 25, 2027 and the remaining one-third of the options will become exercisable on February 25, 2028, the third anniversary of the grant date.
FAQ
What insider transaction did HIG disclose on this Form 4?
How many options remain from the exercised HIG option grant?
What other HIG stock option grants are outstanding for the reporting person?
What position does the reporting person hold at HIG?
